Stay updated on Regeneron Press Releases

Sign up to get notified when there's something new on the Regeneron Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Regeneron Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new October 6, 2026 press release highlights Regeneron’s advances in cancer care and related complications at ESMO 2026. The June 22, 2026 release about FDA and EMA review of cemdisiran submissions is no longer listed.
    Difference
    2%
    Check dated 2026-10-10T14:45:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Three October 1, 2026 releases announce durable responses in an ovarian cancer study, muscle-loss prevention findings from the COURAGE trial, and an expanded Regeneron–Sanofi immunology alliance. Older releases from May and June 2026 are no longer listed.
    Difference
    6%
    Check dated 2026-10-03T14:34:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a new entry for Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026 (dated September 24, 2026 4:05 PM EDT). Removed the Lynozyfic® (linvoseltamab) Monotherapy press release (dated May 21, 2026 5:01 PM EDT) from the listing.
    Difference
    2%
    Check dated 2026-09-26T17:19:30.000Z thumbnail image
  4. Check
    55 days ago
    Change Detected
    Summary
    Two new press releases were added to the page—one announcing investor conference presentations and another detailing Pasatru’s FDA-approved trial results—highlighting fresh investor-focused news. Older May 2026 entries were removed, reflecting archival cleanup of outdated items.
    Difference
    6%
    Check dated 2026-08-22T20:43:25.000Z thumbnail image
  5. Check
    76 days ago
    Change Detected
    Summary
    New items added to the press releases list include Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation (July 31, 2026) and Regeneron Reports Second Quarter 2026 Financial and Operating Results (July 30, 2026). Older entries were removed (May 15 and May 8, 2026), reflecting an updated, chronological feed on the page.
    Difference
    6%
    Check dated 2026-08-01T13:57:44.000Z thumbnail image
  6. Check
    112 days ago
    Change Detected
    Summary
    Two new press releases were added (Q2 2026 financial results and Cemdisiran regulatory submissions). Two older items were removed (Dupixent EoE Phase 4 update and Q1 2026 results).
    Difference
    6%
    Check dated 2026-06-26T19:28:16.000Z thumbnail image

Stay in the know with updates to Regeneron Press Releases

Enter your email address, and we'll notify you when there's something new on the Regeneron Press Releases page.